A growing repertoire of cell and molecule-based immunotherapies is offering patients with indomitable cancers new hope by mobilizing their immune systems against tumor cells. An emerging class of such immunotherapeutics, ...
Aug 23, 2023
0
36
Glioblastoma is a swift and aggressive brain cancer, with an average life expectancy of about one year after diagnosis. It's difficult to treat, in part because the cellular makeup of each tumor varies greatly from person ...
Aug 23, 2023
0
37
A study by researchers from Karolinska Institutet and physicians from Karolinska Hospital shows that a capsule of connective tissue around liver metastases from colorectal cancer improves patient survival and represents a ...
Aug 22, 2023
0
43
Stem cells are special kinds of cells in our body that can become any other type of cell. They have huge potential for medicine, and trials are currently under way using stem cells to replace damaged cells in diseases like ...
Aug 20, 2023
0
65
Chandra Mohan, Hugh Roy and Lillie Cranz Cullen Endowed Professor of biomedical engineering, is reporting the first use of the powerful imaging mass cytometry (IMC) to examine the kidneys of patients with lupus (systemic ...
Aug 17, 2023
0
1
A study from the University of Michigan Rogel Cancer Center uncovers a new mechanism to explain why some prostate tumors switch from a common, treatable form to a more rare and aggressive form of prostate cancer.
Aug 14, 2023
0
13
The National Institutes of Health is releasing a comprehensive dataset that standardizes genomic, proteomic, imaging, and clinical data from individual studies of more than 1,000 tumors across 10 cancer types. Researchers ...
Aug 14, 2023
0
5
Though almost every cell in your body contains a copy of each of your genes, only a small fraction of these genes will be expressed, or turned on. These activations are controlled by specialized snippets of DNA called enhancers, ...
Aug 10, 2023
0
116
A team of researchers from the Keck School of Medicine of USC have published the first detailed description of the interplay between two cell types that allow lizards to regenerate their tails. This research, published on ...
Aug 10, 2023
0
138
Overly active immune cells are often behind lung damage in diseases such as COVID-19. Researchers at the Technical University of Munich (TUM) have developed an RNA agent for a lung spray that slows the activity of these cells, ...
Aug 8, 2023
0
32
